n/a
Article Publish Status: FREE
Abstract Title:

Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome.

Abstract Source:

Pharmaceuticals (Basel). 2022 Jan 19 ;15(2). Epub 2022 Jan 19. PMID: 35215230

Abstract Author(s):

Andrea Valeri, Luigi Chiricosta, Agnese Gugliandolo, Federica Pollastro, Emanuela Mazzon

Article Affiliation:

Andrea Valeri

Abstract:

Spinal cord injury affects the lives of millions of people around the world, often causing disability and, in unfortunate circumstances, death. Rehabilitation can partly improve outcomes and only a small percentage of patients, typically the least injured, can hope to return to normal living conditions.is gaining more and more interest in recent years, even though its beneficial properties have been known for thousands of years. Cannabigerol (CBG), extracted from, is defined as the "mother of all cannabinoids" and its properties range from anti-inflammatory to antioxidant and neuroprotection. Using NSC-34 cells to model spinal cord injury in vitro, our work evaluated the properties of CBG treatments in motor neuron regeneration. While pre-treatment can modulate oxidative stress and increase antioxidant enzyme genes, such as, decreasingpost-treatment seems to induce regeneration genes by triggering different pathways, such asvia p53 acetylation byandandviasignaling, along with cytoskeletal remodeling signaling genesand. Our results indicate CBG as a phytocompound worth further investigation in the field of neuronal regeneration.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.